久久偷看各类wc女厕嘘嘘偷窃,国语对白农村老太婆bbw,久久婷婷五月综合色欧美,久久人与动人物a级毛片,久久久亚洲欧洲日产国码是av

Ly6k (E4K8Y) XP Rabbit mAb



商城價: 登錄可見

品    牌:CST/賽信通

貨    號:44263T

規(guī)    格:

運費: 登錄后可查看運費

DeepBio得分:
DeepBio得分 是基于文獻引用次數,影響因子,文獻新近度等因素計算的客觀產品評級,得分越高表明該產品經過越可靠的實驗驗證,質量可信度越高
1家供應商在售
商品名稱 規(guī)格 代理級別 價格 運費 供應商 購買
Ly6k (E4K8Y) XP ? Rabbit mAb
交貨周期:現貨
20 μl 經銷
登錄可見

-

北京敏泰元科技有限公司
庫存:20

  • 產品詳情

應用:W, IP, IHC-Bond, IHC-P
Cancer/testis antigens (CTAs) are a family of more than 100 proteins whose normal expression is largely restricted to immune privileged germ cells of the testis, ovary, and trophoblast cells of the placenta. Although most normal somatic tissues are void of CTA expression, due to epigenetic silencing of gene expression, their expression is upregulated in a wide variety of human solid and liquid tumors (1,2). As such, CTAs have garnered much attention as attractive targets for a variety of immunotherapy-based approaches to selectively attack tumors (3).Ly6k is a member of the Ly6/urokinase type plasminogen activator receptor-like protein (uPAR)(LU) superfamily. It is expressed in testes where in interaction with another (uPAR)(LU) family member, TEX101, it is proposed to be necessary for the production of viable sperm (4). The human ortholog of this protein, LY6K, has been characterized to be a CTA. It is found to be upregulated in numerous types of cancer, including esophageal squamous cell carcinoma, bladder cancer, and breast cancer (5,6).

Supporting Data

REACTIVITY M
SENSITIVITY Endogenous
MW (kDa) 18
Source/Isotype Rabbit IgG

Application Key:

  • W-Western
  • IP-Immunoprecipitation
  • IHC-Immunohistochemistry
  • ChIP-Chromatin Immunoprecipitation
  • IF-Immunofluorescence
  • F-Flow Cytometry
  • E-P-ELISA-Peptide

Species Cross-Reactivity Key:

  • H-Human
  • M-Mouse
  • R-Rat
  • Hm-Hamster
  • Mk-Monkey
  • Vir-Virus
  • Mi-Mink
  • C-Chicken
  • Dm-D. melanogaster
  • X-Xenopus
  • Z-Zebrafish
  • B-Bovine
  • Dg-Dog
  • Pg-Pig
  • Sc-S. cerevisiae
  • Ce-C. elegans
  • Hr-Horse
  • All-All Species Expected

Product Usage Information

Application Dilution
Western Blotting 1:1000
Immunoprecipitation 1:200
IHC-Leica? Bond? 1:200 - 1:800
Immunohistochemistry (Paraffin) 1:200 - 1:800

Storage

Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 μg/ml BSA, 50% glycerol and less than 0.02% sodium azide. Store at –20°C. Do not aliquot the antibody.

Specificity / Sensitivity

Ly6k (E4K8Y) XP? Rabbit mAb recognizes endogenous levels of total Ly6k protein.

Species Reactivity:

Mouse

Source / Purification

Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Pro70 of murine Ly6k protein.

Background

Cancer/testis antigens (CTAs) are a family of more than 100 proteins whose normal expression is largely restricted to immune privileged germ cells of the testis, ovary, and trophoblast cells of the placenta. Although most normal somatic tissues are void of CTA expression, due to epigenetic silencing of gene expression, their expression is upregulated in a wide variety of human solid and liquid tumors (1,2). As such, CTAs have garnered much attention as attractive targets for a variety of immunotherapy-based approaches to selectively attack tumors (3).

Ly6k is a member of the Ly6/urokinase type plasminogen activator receptor-like protein (uPAR)(LU) superfamily. It is expressed in testes where in interaction with another (uPAR)(LU) family member, TEX101, it is proposed to be necessary for the production of viable sperm (4). The human ortholog of this protein, LY6K, has been characterized to be a CTA. It is found to be upregulated in numerous types of cancer, including esophageal squamous cell carcinoma, bladder cancer, and breast cancer (5,6).

  1. Caballero, O.L. and Chen, Y.T. (2009) Cancer Sci 100, 2014-21.
  2. De Smet, C. et al. (1999) Mol Cell Biol 19, 7327-35.
  3. Gjerstorff, M.F. et al. (2015) Oncotarget 6, 15772-87.
  4. Endo, S. et al. (2016) Sci Rep 6, 23616.
  5. Ishikawa, N. et al. (2007) Cancer Res 67, 11601-11.
  6. Kono, K. et al. (2009) Cancer Sci 100, 1502-9.

友情鏈接 :  中國科學院 國科控股 喀斯瑪控股有限公司 中科海外人才創(chuàng)業(yè)園

商城介紹 | 媒體報道 | 法規(guī)政策 | 協(xié)議專區(qū)

京公網安備 11010802025067號 增值電信業(yè)務經營許可證:京B2-20171454 ICP備案號:京ICP備16050672號-1 喀斯瑪科技版權所有 2017-

藥品醫(yī)療器械網絡信息服務備案: (京)-網藥械信息備字(2022)第00393號 醫(yī)療器械網絡交易服務第三方平臺備案編號:京網械平臺備字(2021)第00006號

網絡食品交易第三方平臺提供者備案 :京食藥網食備202110062 信息系統(tǒng)安全等級保護備案證明(三級)